# Clustering Approach 7 : MIRSEQ_CNMF
Index	Clinical feature name	Test type	P value	Comment
1	Time to Death	logrank test	0.424719968799882	Range of duration = 2.56 to 345.96, nDeath = 69, nCensor = 73
2	AGE	ANOVA	0.0885006680393482	Range of values = 18 to 87, Mean = 55.9167, StdDev = 15.7811
3	PRIMARY.SITE.OF.DISEASE	Fisher's exact test	0.00303910323064985	nTypes = 2 (REGIONAL CUTANEOUS OR SUBCUTANEOUS TISSUE (INCLUDES SATELLITE AND IN-TRANSIT METASTASIS)/REGIONAL LYMPH NODE), nPatients = 34/110
4	GENDER	Fisher's exact test	0.584771141874265	nTypes = 2 (FEMALE/MALE), nPatients = 50/94
5	DISTANT.METASTASIS	Chi-square test	0.263458257854567	nTypes = 5 (M0/M1/M1A/M1B/M1C), nPatients = 125/1/2/2/1, nMissing = 13
6	LYMPH.NODE.METASTASIS	Chi-square test	0.80943944572246	nTypes = 10 (N0/N1/N1A/N1B/N2/N2A/N2B/N2C/N3/NX), nPatients = 75/2/6/12/1/4/11/4/15/2, nMissing = 12
7	TUMOR.STAGECODE	ANOVA	NA	Range of values = Inf to -Inf, Mean = NaN, StdDev = NA, nMissing = 144
8	NEOPLASM.DISEASESTAGE	Chi-square test	0.0443791067856485	nTypes = 13 (I OR II NOS/STAGE I/STAGE IA/STAGE IB/STAGE II/STAGE IIA/STAGE IIB/STAGE IIC/STAGE III/STAGE IIIA/STAGE IIIB/STAGE IIIC/STAGE IV), nPatients = 1/16/8/13/16/6/8/4/8/5/16/20/4, nMissing = 19
